MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Asset Writedowns and Impairment (2023 - 2024)

MeiraGTx Holdings' (MGTX) quarterly Asset Writedowns and Impairment came in at -$409000.0 in Q4 2024, down 438.16% YoY from $120949.4 in Q1 2024, and down 2456.25% on a QoQ basis from -$16000.0 in Q3 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

MeiraGTx Holdings (MGTX) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

MeiraGTx Holdings (MGTX) has 2 years of Asset Writedowns and Impairment data on file, last reported at -$409000.0 in Q4 2024.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -409,000.00
Sep 30, 2024 -16,000.00
Dec 31, 2023 -76,000.00